Close Menu

NEW YORK (360Dx) — Alere said yesterday that it has appealed a decision by the Centers for Medicare and Medicaid Services (CMS) to revoke the Medicare billing privileges of the diagnostic company's diabetes unit, Arriva Medical.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.